
	Where results make sense

Topic: Arvid Carlsson

Related Topics

Parkinsons disease

Nigrostriatal pathway

Dopamine

Paul Greengard

Substantia nigra

Charles Louis Alphonse Laveran

Ilya Ilyich Mechnikov

Neurotransmitter

Nobel Prize in Physiology or Medicine

Emil Theodor Kocher

Arvid Horn

Santiago Ramon y Cajal

Emil Adolf von Behring

Sweden

Columbia University

	ARVID CARLSSON — A PRESENTATION (Site not responding. Last check: 2007-10-10)
		Arvid Carlsson, co-author of “Messengers of the Brain”;, is professor emeritus of pharmacology at the University of Gothenburg.
		Arvid Carlsson was awarded the Nobel Prize of medicine and physiology in 2000, for his studies in the nineteen-fifties and -sixties on how brain cells transmit signals to each other, with the help of chemical messengers, neurotransmitters.
		Arvid Carlsson has been called “the Father of Dopamine”; for his discovery of the neurotransmitter dopamine, which is of vital importance for the muscular movements and the mental functions.
	www.brainmessenger.com /brain_eng02.htm (344 words)

	Arvid Carlsson Biography \| World of Genetics
		Arvid Carlsson received the Nobel Prize for his discovery that dopamine is a neurotransmitter.
		Arvid Carlsson's groundbreaking research in the 1950's established the relationship between neurotransmitters and diseases of the central nervous system when he discovered that a depleted neurotransmitter causes Parkinson's disease, a debilitating brain condition named after the English doctor who first described it in 1817.
		Carlsson also discovered that the dysregulation of another neurotransmitter, serotonin, causes clinical depression and several other behavioral disorders, including OCD (Obsessive- Compulsive Disorder), obesity, violent and aggressive behaviors, and suicide, one of the ten leading causes of death in the United States.
	www.bookrags.com /biography/arvid-carlsson-wog (816 words)

	Neurological Foundation of New Zealand
		Arvid Carlsson has made a number of subsequent discoveries, which have further clarified the role of dopamine in the brain, demonstrating the mode of action of drugs used for the treatment of schizophrenia.
		Arvid Carlsson performed a series of pioneering studies during the late 1950's which showed that dopamine is an important transmitter in the brain.
		Arvid Carlsson showed that there were particularly high levels of the chemical transmitter dopamine in the so called basal ganglia of the brain, which are of major importance for instance for the control of our muscle movements.
	www.neurological.org.nz /html/article.php?documentCode=37 (2099 words)

	Reference.com/Encyclopedia/Arvid Carlsson
		Carlsson won the Nobel Prize in Physiology or Medicine in 2000 along with co-recipients Eric Kandel and Paul Greengard.
		Carlsson was born in Uppsala, Sweden, son of Gottfrid Carlsson, historian and later professor of history at the Lund University, where he began his medical education in 1941.
		In the 1950s, Carlsson demonstrated that dopamine was a neurotransmitter in the brain and not just a precursor for norepinephrine, as had been previously believed.
	www.reference.com /browse/wiki/Arvid_Carlsson (328 words)

	Dr Arvid Carlsson, Nobel Laureate in Medicine, Opposes Fluoridation
		Carlsson was awarded the Nobel Prize for his discovery of how brain cells transmit signals to each other, laying the groundwork for improved treatments for neurological and psychiatric disorders.
		Carlsson's concern regarding the dangers of fluoridation echo the worries of University of Toronto dental professor Dr. Hardy Limeback.
		Carlsson has since the early 70's criticized Socialstyrelsen for its unscientific view on fluoridation and ignorance to consider the documented damage of teeth of individuals grown up in areas with high fluoride content in the drinking water.
	www.fluoridealert.org /carlsson.htm (1680 words)

	Arvid Carlsson Summary
		Arvid Carlsson, along with Paul Greengard and Eric Kandel, received the Nobel Prize in Medicine or Physiology in 2000 for work concerning signal transduction in the nervous system.
		Carlsson also discovered that the dysregulation of another neurotransmitter, serotonin, causes clinical depression and several other behavioral disorders, including OCD (Obsessive-Compulsive Disorder), obesity, violent and aggressive behaviors, and suicide, one of the ten leading causes of death in the United States.
		Carlsson was born in Uppsala, Sweden, son of Gottfrid Carlsson, historian and later professor of history at the University of Lund, where he began his medical education in 1941.
	www.bookrags.com /Arvid_Carlsson (1928 words)

	Digital Journal
		Carlsson, 77, is with the University of Goteborg in Sweden, Greengard, 74, is with Rockefeller University in New York and Kandel, 70, is an Austrian-born U.S. citizen with Columbia University in New York.
		Carlsson's studies during the late 1950s led to the discovery of the drug L-dopa, used to treat Parkinson's disease, which is still the most important treatment for the disease, the committee said.
		Arvid Carlsson, Department of Pharmacology, University of Gothenburg is rewarded for his discovery that dopamine is a transmitter in the brain and that it has great importance for our ability to control movements.
	www.digitaljournal.com /print/article/31896 (1136 words)

	Arvid Carlsson - Autobiography
		The publication of these findings (Carlsson and Serin, 1950) appears to have been the first describing a circadian rhythm of a drug's action, according to a review article on chronobiology, that was published much later when this subject became fashionable in connection with space research.
		CARLSSON, M., and A. The NMDA antagonist MK-801 causes marke locomotor stimulation in monoamine-depleted mice.
		CARLSSON, M., and A. Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice.
	nobelprize.org /nobel_prizes/medicine/laureates/2000/carlsson-autobio.html (2094 words)

	CiplaDocs - Publications - Current Medical Scene
		Arvid Carlsson, Department of Pharmaco-logy, University of Gothenburg is rewarded for his discovery in the late 1950s, that dopamine is a transmitter in the brain and that it has great importance for our ability to control movements.
		Arvid Carlsson realized that the symptoms caused by reserpine were similar to the syndrome of Parkinson’s disease.
		The discoveries of Arvid Carlsson have had great importance for the treatment of depression, which is one of the most common diseases.
	www.cipladoc.com /publications/cms/issue6/cms01.htm (1241 words)

	NIH Record-3/19/2002--Nobelist Carlsson To Give Director's Lecture, Apr. 3
		When the Nobel committee awarded the 2000 Nobel Prize in Medicine to Arvid Carlsson and his fellow neuroscientists Paul Greengard and Eric Kandel, it was a long-awaited recognition of the fundamental contributions Carlsson has made to advance understanding of synaptic transmission.
		Carlsson stepped into an area of research that was ripe with the potential for discoveries.
		Carlsson continues to work on the biochemistry of Parkinson's disease and schizophrenia through his research firm, Carlsson Research Inc. He is also a professor emeritus in pharmacology at the University of Göteborg.
	www.nih.gov /news/NIH-Record/03_19_2002/story03.htm (559 words)

	Yer 2000's Nobel Prize
		Arvid Carlsson (University of Gothenburg, Sweden) Working at the NIH in the 1950s, Arvid Carlsson was one of an army of scientists trying to sort out how the brain changes from day to day.
		Mood and memory were blank slates, their mechanism a mystery, but brain scientists like Carlsson suspected that the bizarre zoo of chemicals present in the brain might provide a clue.
		Measuring levels of dopamine in different parts of the brain, Carlsson found that there was an awful lot of it in the corpus striatum, the part of the brain that regulates movement.
	www.txtwriter.com /onscience/Articles/nobel2000.html (816 words)

	GU - The Sahlgrenska Academy - Noble Prize winner Arvid Carlsson
		In 2000 Professor Emeritus Arvid Carlsson was awarded the Nobel Prize for his research in neuropharmacology.
		No less than 40 years ago, Arvid Carlsson was able to show that dopamine acts as a messenger molecule, and that a lack of this substance resulted in impaired motor ability, such as that associated with Parkinson’s disease.
		Arvid Carlsson and his colleagues were also the first to realize that selective strengthening of the signal substance serotonin was an efficient and gentle way of treating depression.
	www.sahlgrenska.gu.se /english/research/carlsson/?adjust=true&textFontSize=null&letterSpace=null&fontFamily=null&textLineHeight=null&contrast=null&wordspace=null (409 words)

	NARSAD: News & Events: NARSAD Research Newsletter Archive
		Arvid Carlsson, M.D., now Professor and Chairman of the Department of Pharmacology at the University of Gothenburg in Sweden, discovered in the 1950's that dopamine acts as a neurotransmitter in the brain, sending signals from one cell to another.
		Carlsson's discovery led to an understanding that Parkinsonism results from the death of dopamine neurons in the substantia nigra and that dopamine is a key neurotransmitter involved with motivation-literally the ability to decide to start or stop moving.
		Carlsson received the Lieber Prize for Outstanding Research in Schizophrenia in 1994, for his work on dopamine and in establishing that tricyclic antidepressants affect the neurotransmitter serotonin.
	www.narsad.org /news/newsletter/researchers/bio2003-07-08c.html (1654 words)

	ZoomInfo Web Summary: Arvid Carlsson
		Carlsson is also currently CEO of Carlsson Research, a development stage neuroscience company that grew out of his research in the Department of Pharmacology at the University of Göteborg, Sweden.
		Carlsson is Professor Emeritus at the University of Göteborg and is a member of the Swedish Academy of Sciences and a foreign affiliate of the U.S. National Academy of Sciences.
		Carlsson is currently Chief Executive Officer of Carlsson Research, a development stage neuroscience company that grew out of his research in the Department of Pharmacology at the University of Göteborg, Sweden.
	www.zoominfo.com /Search/PersonDetail.aspx?PersonID=27285368 (976 words)

	Cortex Corporate — Scientific Advisors (Site not responding. Last check: 2007-10-10)
		Carlsson is a scientific advisor to Cortex’s Board of Directors and was the co-recipient of the 2000 Nobel Prize for Medicine.
		Dr. Carlsson is also currently CEO of Carlsson Research, a development stage neuroscience company that grew out of his research in the Department of Pharmacology at the University of Göteborg, Sweden.
		Dr. Carlsson is Professor Emeritus at the University of Göteborg and is a member of the Swedish Academy of Sciences and a foreign affiliate of the U.S. National Academy of Sciences.
	www.cortexpharm.com /html/corp/advisors.html (377 words)

	Biotechnology News and Information Portal, biotech jobs and career resources Resources. (Site not responding. Last check: 2007-10-10)
		Carlsson Research has brought its lead compound, ACR16, which is based on its ISP (Integrative Screening Process) technology, through Phase I and into early clinical testing, with promising results.
		The Swedish research group, founded by Arvid Carlsson, Professor Emeritus of Pharmacology and a legendary neuroscientist at the Gothenburg University, Nobel laureate in Medicine in 2000, and co-founder of Carlsson Research, has an excellent track record of groundbreaking research leading to the development of several important treatment principles and drugs.
		In March 2000 Carlsson Research raised SEK 60 million in an equity financing with Scandinavian Life Science Venture, the leading venture capital fund in the Nordic area, to advance the dopamine stabilizer project through lead discovery, development and early clinical testing.
	www.bioexchange.com /news/news_page.cfm?id=16510 (1103 words)

	Nobel prize for Medicine 2000
		Arvid Carlsson is rewarded for his discovery that dopamine is a transmitter in the brain and that is has great importance for our ability to control movements.
		Carlsson used a naturally occurring substance, reserpine, which depletes the storage of several synaptic transmitters.
		The discoveries of Arvid Carlsson have had great importance for the treatment of depression, which is one of our most common diseases.
	www.manbir-online.com /news/nobel-2000.htm (475 words)

	Arvid Carlsson - Wikipedia, den fria encyklopedin
		Arvid Carlsson, född 25 januari 1923, farmakolog; professor vid Göteborgs universitet 1959-89, mottagare av nobelpriset i fysiologi eller medicin år 2000.
		Son till Gottfrid Carlsson, bror till Sten Carlsson.
		Arvid Carlsson, har upptäckt att dopamin är en sådan signalsubstans i hjärnan och att dopamin har stor betydelse för kontroll av våra rörelser.
	sv.wikipedia.org /wiki/Arvid_Carlsson (264 words)

	Water Fluoridation "Obsolete" According to Nobel Prize Scientist
		On October 4, 2005, two members of the Fluoride Action Network -- Michael Connett and Chris Neurath -- traveled to Gothenburg, Sweden, to interview Dr. Arvid Carlsson, a famed pharmacologist at Gothenburg University and recent winner of the Nobel Prize in Medicine/Physiology.
		In the 1970s, Dr. Carlsson was an outspoken opponent of two failed attempts to fluoridate water supplies in Sweden.
		CARLSSON: Well, in pharmacology, if the effect is local, it's of course absolutely awkward to use it in any other way than as a local treatment.
	www.fluoridealert.org /carlsson-interview.html (641 words)

	Cortex News & Events
		Carlsson is currently CEO of Carlsson Research, a development stage neuroscience company that grew out of his research in the Department of Pharmacology at the University of Göteborg, Sweden.
		In the 1980’s, Dr. Carlsson recognized the importance of restoring a balance between the neurotransmitters dopamine and glutamate in the treatment of schizophrenia, which ultimately led Cortex to evaluate the use of its AMPAKINE® technology for the treatment of schizophrenia.
		In 1955, Dr. Carlsson was selected to be a trainee at the National Institutes of Health in Bethesda, MD, where he studied the biochemical role of reserpine in the brain in relationship to the neurotransmitter serotonin.
	www.cortexpharm.com /html/news/02/04-24-02.html (910 words)

	CJ Online \| News \| Two Americans, Swede win Nobel for brain studies 10/10/00
		Arvid Carlsson, Paul Greengard and Eric Kandel will share the $915,000 prize for pioneering work that could lead to new treatments for schizophrenia, Alzheimer's disease, addiction and other mental disorders.
		Carlsson, 77, is with the University of Goteborg in Sweden.
		Carlsson was honored for work in the late 1950s that showed a substance called dopamine is a key messenger between brain cells.
	www.cjonline.com /stories/101000/new_nobelprize10.shtml (606 words)

	The Hindu : Synaptic transmission nets award
		Arvid Carlsson developed an assay that made it possible to measure tissue levels of dopamine with high sensitivity.
		In a series of experiments Carlsson used a naturally occurring substance, reserpine, which depletes the storage of several synaptic transmitters.
		Arvid Carlsson realised that the symptoms caused by reserpine were similar to the syndrome of Parkinson's disease.
	www.hindu.com /2000/10/19/stories/08190002.htm (1357 words)

	Nobel Prize - To Brain Researchers - Health and Medical Information produced by doctors - MedicineNet.com
		Carlsson, Greengard and Kandel underlines the importance today of molecular and cell biology in learning how the brain works.
		Their research is directly relevant to neurologic disorders such as Parkinson disease and schizophrenia as well as the basic brain phenomenon of memory.
		His research has led to the realization that Parkinson's disease is caused by a lack of dopamine in certain parts of the brain and that an efficient remedy (L-dopa) for this disease could be developed.
	www.medicinenet.com /script/main/art.asp?articlekey=14864 (647 words)

	Online NewsHour: Nobel Prize in Medicine -- October 9, 2000
		Sweden's Arvid Carlsson and Americans Paul Greengard and Eric Kandel won the 2000 Nobel Prize for medicine for their research on how messages are transmitted between brain cells.
		Arvid Carlsson's research since the 1950s showed that dopamine is an important transmitter between brain cells and is instrumental in the ability to control physical movement.
		Carlsson's work led to the development of L-dopa, a treatment for Parkinson's Disease.
	www.pbs.org /newshour/nobel2000/medicine.html (274 words)

Try your search on: Qwika (all wikis)